Filter
1418
Filtered Results: 1418
Text search:
adverse
drug
event
Featured
Recommendations
181
New Publications
349
Language
Document type
No document type
794
Guidelines
277
Studies & Reports
171
Manuals
87
Strategic & Response Plan
42
Fact sheets
20
Training Material
14
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
94
Global
43
Western and Central Europe
40
South Africa
34
Ethiopia
30
Kenya
29
Nigeria
24
Latin America and the Carribbean
23
Ghana
22
Bangladesh
18
Uganda
18
Eastern Europe
18
Nepal
15
Africa
15
Tanzania
15
Sierra Leone
12
Philippines
12
South–East Asia Region
12
Liberia
11
Myanmar / Burma
11
Rwanda
9
Zimbabwe
9
Cambodia
9
Namibia
9
Zambia
9
Malawi
8
USA
8
Colombia
7
Asia
7
Eastern Europe and Central Asia
7
Syria
6
Argentina
6
Brazil
6
Ukraine
5
Western Pacific Region
5
East and Southern Africa
5
Botswana
5
Indonesia
5
Mozambique
4
West and Central Africa
4
Eswatini/ Swaziland
4
Timor Leste/ East Timor
3
Thailand
3
Lesotho
3
Germany
3
Middle East and North Africa
3
South Sudan
3
North Macedonia
2
Tajikistan
2
China
2
Chile
2
Laos
2
Congo, Democratic Republic of
2
Paraguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Georgia
2
Angola
2
Bhutan
2
North Korea
1
Australia
1
Kazakhstan
1
Cameroon
1
Albania
1
Fiji
1
Kyrgyzstan
1
Bulgaria
1
Guinea
1
Haiti
1
Guinea-Bissau
1
Ireland
1
North America
1
Belarus
1
Lebanon
1
Sri Lanka
1
Russia
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
447
Clinical Guidelines
230
Public Health
92
Women & Child Health
73
Key Resources
46
Pharmacy & Technologies
24
Capacity Building
21
Toolboxes
TB
154
Mental Health
144
HIV
132
COVID-19
80
Pharmacy
73
NTDs
59
AMR
57
Rapid Response
39
NCDs
32
Caregiver
31
Ebola & Marburg
23
Planetary Health
20
Refugee
18
Global Health Education
16
Specific Hazards
14
Conflict
13
Polio
11
Disability
9
Cholera
7
Natural Hazards
6
Zika
4
Health Financing Toolbox
3
Social Ethics
2
Malaria
2
The objective of the EMTCT Plus initiative is to achieve and sustain the elimination
of mother-to-child transmission of HIV, syphilis, Chagas, and perinatal hepatitis
B (HBV) as a public health threat. It embraces the principles and lines of action
of the Strategy for Universal Access to Health a...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Sector Environmental Guidelines, Full technical Update
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus disease in history. On 11 August 2014, WHO convened a consultation where the participants concluded that in the particular context of the current Ebola outbreak in West Africa, it is ethically acceptable to of...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
